Product Code: ETC417576 | Publication Date: Oct 2022 | Updated Date: Feb 2025 | Product Type: Market Research Report | |
Publisher: 6Wresearch | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 | |
The gastrointestinal diseases market in the UAE is characterized by a growing prevalence of conditions such as irritable bowel syndrome, gastroesophageal reflux disease, and inflammatory bowel disease. Increasing awareness of digestive health and a rising demand for advanced diagnostics and treatments have driven market growth. Healthcare providers and pharmaceutical companies are actively involved in research and development efforts to address these challenges and offer innovative solutions.
The UAE gastrointestinal diseases market has grown due to factors like changes in lifestyle, dietary habits, and an aging population. The incidence of gastrointestinal disorders has increased, leading to a greater demand for diagnostic and therapeutic solutions in this market.
The prevalence of gastrointestinal diseases is on the rise due to changing lifestyles and dietary habits. However, challenges in early diagnosis, access to specialized healthcare, and affordability of treatment can hinder market growth.
The COVID-19 pandemic had a dual impact on the gastrointestinal diseases market in the UAE. On one hand, there was a surge in gastrointestinal issues due to stress and dietary changes. On the other hand, healthcare resources were diverted to manage COVID-19 cases, affecting the diagnosis and treatment of gastrointestinal diseases.
In the UAE gastrointestinal diseases market, leading players include pharmaceutical companies such as Pfizer, Novartis, and Sanofi, as well as healthcare providers like Mediclinic Middle East.
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 United Arab Emirates (UAE) Gastrointestinal Diseases Market Overview |
3.1 United Arab Emirates (UAE) Country Macro Economic Indicators |
3.2 United Arab Emirates (UAE) Gastrointestinal Diseases Market Revenues & Volume, 2021 & 2031F |
3.3 United Arab Emirates (UAE) Gastrointestinal Diseases Market - Industry Life Cycle |
3.4 United Arab Emirates (UAE) Gastrointestinal Diseases Market - Porter's Five Forces |
3.5 United Arab Emirates (UAE) Gastrointestinal Diseases Market Revenues & Volume Share, By Drug Type, 2021 & 2031F |
3.6 United Arab Emirates (UAE) Gastrointestinal Diseases Market Revenues & Volume Share, By Dosage Form, 2021 & 2031F |
3.7 United Arab Emirates (UAE) Gastrointestinal Diseases Market Revenues & Volume Share, By Application, 2021 & 2031F |
4 United Arab Emirates (UAE) Gastrointestinal Diseases Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 United Arab Emirates (UAE) Gastrointestinal Diseases Market Trends |
6 United Arab Emirates (UAE) Gastrointestinal Diseases Market, By Types |
6.1 United Arab Emirates (UAE) Gastrointestinal Diseases Market, By Drug Type |
6.1.1 Overview and Analysis |
6.1.2 United Arab Emirates (UAE) Gastrointestinal Diseases Market Revenues & Volume, By Drug Type, 2021-2031F |
6.1.3 United Arab Emirates (UAE) Gastrointestinal Diseases Market Revenues & Volume, By Antacids, 2021-2031F |
6.1.4 United Arab Emirates (UAE) Gastrointestinal Diseases Market Revenues & Volume, By Laxatives, 2021-2031F |
6.1.5 United Arab Emirates (UAE) Gastrointestinal Diseases Market Revenues & Volume, By Antidiarrheal Agents, 2021-2031F |
6.1.6 United Arab Emirates (UAE) Gastrointestinal Diseases Market Revenues & Volume, By Antiemetics, 2021-2031F |
6.1.7 United Arab Emirates (UAE) Gastrointestinal Diseases Market Revenues & Volume, By Antiulcer Agents, 2021-2031F |
6.1.8 United Arab Emirates (UAE) Gastrointestinal Diseases Market Revenues & Volume, By Other, 2021-2031F |
6.2 United Arab Emirates (UAE) Gastrointestinal Diseases Market, By Dosage Form |
6.2.1 Overview and Analysis |
6.2.2 United Arab Emirates (UAE) Gastrointestinal Diseases Market Revenues & Volume, By Oral, 2021-2031F |
6.2.3 United Arab Emirates (UAE) Gastrointestinal Diseases Market Revenues & Volume, By Parenteral, 2021-2031F |
6.2.4 United Arab Emirates (UAE) Gastrointestinal Diseases Market Revenues & Volume, By Other, 2021-2031F |
6.3 United Arab Emirates (UAE) Gastrointestinal Diseases Market, By Application |
6.3.1 Overview and Analysis |
6.3.2 United Arab Emirates (UAE) Gastrointestinal Diseases Market Revenues & Volume, By Ulcerative Colitis, 2021-2031F |
6.3.3 United Arab Emirates (UAE) Gastrointestinal Diseases Market Revenues & Volume, By Irritable Bowel Syndrome, 2021-2031F |
6.3.4 United Arab Emirates (UAE) Gastrointestinal Diseases Market Revenues & Volume, By Crohn Disease, 2021-2031F |
6.3.5 United Arab Emirates (UAE) Gastrointestinal Diseases Market Revenues & Volume, By Celiac Disease, 2021-2031F |
6.3.6 United Arab Emirates (UAE) Gastrointestinal Diseases Market Revenues & Volume, By Gastroenteritis, 2021-2031F |
6.3.7 United Arab Emirates (UAE) Gastrointestinal Diseases Market Revenues & Volume, By Other, 2021-2031F |
7 United Arab Emirates (UAE) Gastrointestinal Diseases Market Import-Export Trade Statistics |
7.1 United Arab Emirates (UAE) Gastrointestinal Diseases Market Export to Major Countries |
7.2 United Arab Emirates (UAE) Gastrointestinal Diseases Market Imports from Major Countries |
8 United Arab Emirates (UAE) Gastrointestinal Diseases Market Key Performance Indicators |
9 United Arab Emirates (UAE) Gastrointestinal Diseases Market - Opportunity Assessment |
9.1 United Arab Emirates (UAE) Gastrointestinal Diseases Market Opportunity Assessment, By Drug Type, 2021 & 2031F |
9.2 United Arab Emirates (UAE) Gastrointestinal Diseases Market Opportunity Assessment, By Dosage Form, 2021 & 2031F |
9.3 United Arab Emirates (UAE) Gastrointestinal Diseases Market Opportunity Assessment, By Application, 2021 & 2031F |
10 United Arab Emirates (UAE) Gastrointestinal Diseases Market - Competitive Landscape |
10.1 United Arab Emirates (UAE) Gastrointestinal Diseases Market Revenue Share, By Companies, 2024 |
10.2 United Arab Emirates (UAE) Gastrointestinal Diseases Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |